NSE filing, NSE: ARISTO. Summary written from the filing by ALFA Finder's alert engine.
Aristo Bio-Tech and Lifescience Ltd: key numbers
- Share price
- ₹86.00
- Market cap
- ₹58.55 Cr
- Revenue (annual)
- ₹363.7 Cr
- Net profit (annual)
- ₹7.18 Cr
- P/E (TTM)
- 8.2×Sector 34.1×
- Promoter holding
- 73.42%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aristo Bio-Tech and Lifescience Ltd
All →Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered and voted on routine items including financial statements and director appointments.
Aristo Bio-Tech and Lifescience Other Announcement
Aristo Bio-Tech sent a Reg 36(1)(b) web-link letter for its FY 2025-26 Annual Report to shareholders without email IDs. No financial or business event is disclosed.
Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited has issued a notice for its 21st Annual General Meeting to be held on September 30, 2026.
Aristo Bio-Tech and Lifescience H2 FY26 Results: Turns Profitable, Net Profit ₹3 Cr
Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.
- Key figure
- Net profit ₹3 Cr
Aristo Bio-Tech and Lifescience Financial Results
Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.
Aristo Bio-Tech and Lifescience Other Announcement
Aristo Bio-Tech submitted its annual SDD compliance certificate for FY 2025-26. The certificate confirms maintenance of the mandatory structured digital database for insider trading monitoring.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.